Ticker Scorecard - ITCI Basics Company: Intra-Cellular Therapies Inc. IPO Date: December 27, 2013 Sector: Healthcare Industry: Biotech Market Cap: $9.04B Activated in VL: False Average Daily Range Avg Daily Range: $0.75 | 2.43% Avg Daily Range (30 D): $1.21 | 1.42% Avg Daily Range (90 D): $1.10 | 1.35% Institutional Daily Volume Avg Daily Volume: .63M Avg Daily Volume (30 D): 1.59M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 86 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 4,968 Avg Inst. Trade: $2.72M Avg Inst. Trade (30 D): $5.17M Avg Inst. Trade (90 D): $4.87M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.01M Avg Closing Trade (30 D): $9.47M Avg Closing Trade (90 D): $7.68M Avg Closing Volume: 83.88K     News Feb 21, 2025 @ 6:00 PM CAPLYTA’s Strong Market Adoption Propels It... Source: Delveinsight Feb 21, 2025 @ 1:00 PM Intra-Cellular Therapies Reports Fourth Quarter an... Source: Intra-Cellular Therapies, Inc. Feb 4, 2025 @ 6:56 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: N/A Feb 1, 2025 @ 12:30 PM Johnson & Johnson Announces a Major Acquisition. C... Source: The Motley Fool Jan 30, 2025 @ 6:00 PM Chronic Pain Clinical Trial Pipeline Experiences M... Source: Delveinsight Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.87 $-.25 $-.16 Diluted EPS $-.87 $-.25 $-.16 Revenue $ 613.73M $ 175.38M $ 161.39M Gross Profit $ $ $ Net Income / Loss $ -86.37M $ -26.32M $ -16.22M Operating Income / Loss $ -121.62M $ -38.85M $ -27.72M Cost of Revenue $ $ $ Net Cash Flow $ 364.91M $ -228.99M $ 553.49M PE Ratio